John W. Smither, Chief Financial Officer at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 2,000 shares at $42.00 ($82K) on 2015-02-18, disclosed to the SEC on 2015-02-19.
Scheduled sale ($82k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 1,000 | $40K | 48.8% |
| 2 | $42.00 | 1,000 | $42K | 51.2% |
| Total | $41.00 avg | 2,000 | $82K | 100% |
| Filing → |
| GNLX | SELL | 2023-09-14 | $19K | — | Filing → |
| ARQT | SELL | 2021-03-11 | $58K | — | Filing → |
| ARQT | SELL | 2021-03-03 | $26K | — | Filing → |